| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76385-136-01 | 76385-136 | HUMAN PRESCRIPTION DRUG | Metolazone | Metolazone | TABLET | ORAL | 20210330 | N/A | ANDA | ANDA214799 | Bayshore Pharmaceuticals LLC | METOLAZONE | 2.5 mg/1 | 100 TABLET in 1 BOTTLE (76385-136-01) |
| 76385-137-01 | 76385-137 | HUMAN PRESCRIPTION DRUG | Metolazone | Metolazone | TABLET | ORAL | 20210330 | N/A | ANDA | ANDA214799 | Bayshore Pharmaceuticals LLC | METOLAZONE | 5 mg/1 | 100 TABLET in 1 BOTTLE (76385-137-01) |
| 76385-138-01 | 76385-138 | HUMAN PRESCRIPTION DRUG | Metolazone | Metolazone | TABLET | ORAL | 20210330 | N/A | ANDA | ANDA214799 | Bayshore Pharmaceuticals LLC | METOLAZONE | 10 mg/1 | 100 TABLET in 1 BOTTLE (76385-138-01) |